Abstract
Pioneering work in the United States to create organs-on-chips could revolutionise the future of drug development. Four years ago scientists observed how a white blood cell reacts when it senses an infection. They watched the leukocyte as it wriggled through capillary cells — the cells that line blood vessels — and then through the cells that line the lung, to then engulf an invading bacterium. But this was not happening inside a patient, it was happening on a microchip1. “It mimics the human response, it’s amazing to watch,” says Geraldine Hamilton, senior staff scientist at the Wyss Institute for Biologically Inspired Engineering.
Users
Please
log in to take part in the discussion (add own reviews or comments).